Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital ...

The Carlyle Group (NASDAQ:CG – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” ...

Q4 2024 Earnings Call Transcript February 11, 2025 The Carlyle Group Inc. misses on earnings expectations. Reported EPS is $0 ...

The Carlyle Group and SK Capital Partners have agreed to acquire bluebird bio, Inc, a Somerville, Massachusetts-based gene therapy firm, in a take-private deal. According to terms of the agreement, ...

Proceeds Distributed to US Buyout Investors: $5.3 billion throughout the year. The Carlyle Group Inc (NASDAQ:CG) achieved a record performance in 2024, generating over $1.1 billion in fee-related ...

In the latest quarter, 6 analysts provided ratings for Carlyle Group CG, showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ratings, offering a ...

What will a thin-skinned showman do with an institution central to Washington’s cultural life? One expectation is more ...

Schwartz emphasized strategic growth in Global Credit, Global Investment Solutions, and Global Wealth, with combined revenue growth of approximately 40% over two years. Global Credit alone grew its ...

Hello everyone, and welcome to The Carlyle Group Fourth Quarter 2024 Earnings. At this time, all participants are in a listen-only mode. After the speakers' presentation there will be a question ...

From processing giant Stripe to DailyPay, which helps hourly workers get their money faster, 11 payment companies made our ...

Hello, everyone, and welcome to the Carlyle Group fourth-quarter 2024 earnings. (Operator Instructions) Please be advised that today's conference is being recorded. Now, it's my pleasure to turn ...